Andrey Alexeyenko

ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Yasmin Yu, Madhumita Bogdan, Muhammad Zaeem Noman, Santiago Parpal, Elisabetta Bartolini, Kris Van Moer, Simone Caroline Kleinendorst, Kristine Bilgrav Saether, Lionel Trésaugues, Camilla Silvander, Johan Lindström, Jodi Simeon, Mary Jane Timson, Hikmat Al-Hashimi, Bryan D Smith, Daniel L Flynn, Andrey Alexeyenko, Jenny Viklund, Martin Andersson, Jessica Martinsson, Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji
Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy. Molecular oncology 18 (8) (2024)
Zhanna Alekseenko, José M Dias, Andrew F Adler, Mariya Kozhevnikova, Josina Anna van Lunteren, Sara Nolbrant, Ashwini Jeggari, Svitlana Vasylovska, Takashi Yoshitake, Jan Kehr, Marie Carlén, Andrey Alexeyenko, Malin Parmar, Johan Ericson
Robust derivation of transplantable dopamine neurons from human pluripotent stem cells by timed retinoic acid delivery. Nature communications 13 (1) (2022)
Iurii Petrov, Andrey Alexeyenko
Individualized discovery of rare cancer drivers in global network context. eLife 11 (2022)
José M Dias, Zhanna Alekseenko, Ashwini Jeggari, Marcelo Boareto, Jannik Vollmer, Mariya Kozhevnikova, Hui Wang, Michael P Matise, Andrey Alexeyenko, Dagmar Iber, Johan Ericson
A Shh/Gli-driven three-node timer motif controls temporal identity and fate of neural stem cells. Science advances 6 (38) (2020)
Bo Franzén, Andrey Alexeyenko, Masood Kamali-Moghaddam, Thomas Hatschek, Lena Kanter, Torbjörn Ramqvist, Jonas Kierkegaard, Giuseppe Masucci, Gert Auer, Ulf Landegren, Rolf Lewensohn
Protein profiling of fine-needle aspirates reveals subtype-associated immune signatures and involvement of chemokines in breast cancer. Molecular oncology 13 (2) (2019)
Marcela Franco, Ashwini Jeggari, Sylvain Peuget, Franziska Böttger, Galina Selivanova, Andrey Alexeyenko
Prediction of response to anti-cancer drugs becomes robust via network integration of molecular data. Scientific reports 9 (1) (2019)
Bo Franzén, Masood Kamali-Moghaddam, Andrey Alexeyenko, Thomas Hatschek, Susanne Becker, Lotta Wik, Jonas Kierkegaard, Annika Eriksson, Naveen R Muppani, Gert Auer, Ulf Landegren, Rolf Lewensohn
A fine-needle aspiration-based protein signature discriminates benign from malignant breast lesions. Molecular oncology 12 (9) (2018)
Torbjörn Ramqvist, Anders Näsman, Bo Franzén, Cinzia Bersani, Andrey Alexeyenko, Susanne Becker, Linnea Haeggblom, Aeneas Kolev, Tina Dalianis, Eva Munck-Wikland
Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome. International journal of molecular sciences 19 (4) (2018)
Stefania Giacomello, Fredrik Salmén, Barbara K Terebieniec, Sanja Vickovic, José Fernandez Navarro, Andrey Alexeyenko, Johan Reimegård, Lauren S McKee, Chanaka Mannapperuma, Vincent Bulone, Patrik L Ståhl, Jens F Sundström, Nathaniel R Street, Joakim Lundeberg
Spatially resolved transcriptome profiling in model plant species. Nature plants 3 (2017)

Andrey Alexeyenko.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrey Alexeyenko